Tak Paul Peter's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Dec 12, 2022
- Accession no.
- 0001209191-22-060689
- Filed
- Dec 12, 2022
- Trade date
- Dec 8-9, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $30.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tak Paul PeterCIK 0001873905 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Common Stock | PPurchaseAcquired | +3,050 | $1.70 | +$5,185 | 28,050 | Direct | |
| Dec 9, 2022 | Common Stock | PPurchaseAcquired | +12,935 | $1.92 | +$24,835.2 | 40,985 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.